TABLE 3.
Unadjusted | Adjusted | |||||
---|---|---|---|---|---|---|
Association | Mixed association | No association | Association | Mixed association | No association | |
Decreased side‐effect severity (eg milder compared to more severe) | (34) study 1; (34) study 2; (43);(63);(87) | (28, 29) study 1; (29, 32) study 2; (42) | (40);(84, 85) | |||
Increased side‐effect severity (eg more severe compared to milder) | (84, 85) | |||||
Increased likelihood or frequency of side‐effects | (2730) study 1; (29, 32) study 2; (42);(43);(77) risk design study;(78) | (50);(72) study 1; (72) study 2 | (30) study 1; (40);(77) risk design study | (38) | ||
Previous experience of symptoms from intervention | (54, 55);(64);(71) | (87) | (80) | (64) | (71);(83) | |
No previous experience of intervention | (48) study 1; (48) study 2 | (73) | ||||
History of illness | (48) study 1; (48) study 2 | |||||
Family history of illness | (73) | |||||
Lower effectiveness of medication | (49) | (77) benefit design study; (77) risk design study | (37) | (49) | (77) benefit design study; (77) risk design study | (38) |
Existing physical symptoms | (48) study 2 | (64) | (47);(48); study 1; (50);(89) | (51);(52) | (64);(73) | (49);(83) |
Increased severity of existing physical symptom | (51) | (49) | ||||
History of nausea and vomiting in past experiences (eg pregnancy, motion sickness, anxiety). |
(64) | (50) | (64) | |||
Lower pre‐treatment quality of life/ worse general well‐being/ health status | (49);(51) | (39) | (84, 85) | (38) | ||
Increased disease severity | (30) study 1 | (37) | (30) study 1 |